Dopamine and Risky Decision-Making in Gambling Disorder - ohsw
Tracking # 20-983926
$99999.00
There are no ratings for this course
Learn moreCourse overview
Gambling disorder is a behavioral addiction associated with impairments in value-based decision-making and cognitive control. These functions are thought to be regulated by dopamine within fronto-striatal circuits, but the role of altered dopamine neurotransmission in the etiology of gambling disorder remains controversial. Preliminary evidence suggests that increasing frontal dopamine tone might improve cognitive functioning in gambling disorder. We therefore examined whether increasing frontal dopamine tone via a single dose of the catechol-O-methyltransferase (COMT) inhibitor tolcapone would reduce risky choice in human gamblers. This course is based on the reading-based online article, Dopamine and Risky Decision-Making in Gambling Disorder created by Jan Peters, PhD and Taylor Vega in 2020.
Subject areas
This course counts toward the state boards and subject areas below.
Ohio Counselor, Social Worker and Marriage and Family Therapist Board
Licensed Independent Marriage and Family Therapist
Licensed Independent Social Worker
Licensed Social Worker
Marriage and Family Therapist
Registered Social Worker Assistant
Disclosure statements
##### Disclosure of Relevant Financial Relationships
CE Learning Systems, LLC is an independent provider of continuing medical education. CE Learning Systems, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, CE Learning Systems, LLC is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest).
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and
- - any investigational, off-label, or non-FDA approved content or discussion
- CE Learning Systems, LLC has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
- Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- - All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- - All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- - Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
- ##### Planners
- The planners have reported the following: There are no relevant disclosures.
- ##### Course Material Authors
- The authors have disclosed any disclosures within the material.
- ##### Course Creator: Abimbola Farinde, PhD, PharmD, LCDC, LPC
- There are no relevant disclosures.
- ##### Commercial support
- There is no commercial support for this distance-learning course.